Milk Fat Globule-Epidermal Growth Factor 8 Exerts Anti-Osteoarthritis Effects by Inhibiting Apoptosis and Inducing Autophagy in Mouse Chondrocytes
Yang Gao,Jian Feng,Qiang Chen,Zhe Wang,Zhihua Yang
DOI: https://doi.org/10.1016/j.bbrc.2024.151022
IF: 3.1
2024-01-01
Biochemical and Biophysical Research Communications
Abstract:Osteoarthritis (OA) is a chronic degenerative joint disease, characterized by cartilage injury. Milk fat globule-epidermal growth factor 8 (MFG-E8) exhibited anti-inflammatory effects, with undefined mechanism in OA. Eighteen C57BL/6J mice were randomized into Sham and destabilization of medial meniscus (DMM) groups, with DMM surgery for OA model establishment. Subsequently, DMM mice received rmMFG-E8 (50 ng/g) as rmMFG-E8 group (n=6). HE staining and Safranin O/Fast green staining for cartilage tissue pathological damage, TUNEL staining for apoptosis, ELISA for pro-inflammatory factors, and immunohistochemistry were performed. Following extraction of primary mouse chondrocytes, cells were randomized into Control, OA (10 ng/mL IL-1β), OA+rmMFG-E8 (500 ng/mL), and OA+rmMFG-E8+3-MA (autophagy inhibitor, 5 mM) groups. Cell viability by CCK8, pro-inflammatory factors by qRT-PCR, and apoptosis by flow cytometry were detected. In vivo and in vitro, transmission electron microscopy for autophagy, and western blot for autophagy- and apoptosis-related expression was conducted. In vivo, DMM group showed severe cartilage tissue damage, higher matrix metalloproteinase 13 (MMP13), Cleaved caspase-3, Cleaved PARP, Bax, TNF-α, IL-1β, IL-6 levels, and lower Bcl-2, MFG-E8, Collagen II, LC3II/LC3I, Beclin1, and ATG5 expression. Further rmMFG-E8 intervention improved mobility and pathological damage in DMM mice, with lower MMP13 expression. In vitro, rmMFG-E8 in OA group reduced TNF-α, IL-1β, IL-6, Cleaved caspase-3, Cleaved PARP, Bax, and P62 levels, and enhanced cell viability, Bcl-2, LC3II/LC3I, Beclin1, and ATG5 expression. Further 3-MA treatment up-regulated apoptosis and decreased cell viability and autophagy. Therefore, MFG-E8 exerts anti-OA effects by inhibiting apoptosis and inducing autophagy, offering a new potential target for OA treatment.